210 related articles for article (PubMed ID: 34344453)
1. The role of MMP-14 in ovarian cancer: a systematic review.
Vos MC; van der Wurff AAM; van Kuppevelt TH; Massuger LFAG
J Ovarian Res; 2021 Aug; 14(1):101. PubMed ID: 34344453
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia promotes HO-8910PM ovarian cancer cell invasion via Snail-mediated MT1-MMP upregulation.
Sun L; Lin P; Qin Z; Liu Y; Deng LL; Lu C
Exp Biol Med (Maywood); 2015 Nov; 240(11):1434-45. PubMed ID: 25681470
[TBL] [Abstract][Full Text] [Related]
3. Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer.
Vos MC; van der Wurff AA; Bulten J; Kruitwagen R; Feijen H; van Kuppevelt TH; Hendriks T; Massuger LF
Diagn Pathol; 2016 Apr; 11():34. PubMed ID: 27038607
[TBL] [Abstract][Full Text] [Related]
4. Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer.
Kaimal R; Aljumaily R; Tressel SL; Pradhan RV; Covic L; Kuliopulos A; Zarwan C; Kim YB; Sharifi S; Agarwal A
Cancer Res; 2013 Apr; 73(8):2457-2467. PubMed ID: 23423981
[TBL] [Abstract][Full Text] [Related]
5. Matrix Metalloproteinase Expressions Play Important role in Prediction of Ovarian Cancer Outcome.
Wang S; Jia J; Liu D; Wang M; Wang Z; Li X; Wang H; Rui Y; Liu Z; Guo W; Nie J; Dai H
Sci Rep; 2019 Aug; 9(1):11677. PubMed ID: 31406154
[TBL] [Abstract][Full Text] [Related]
6. Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma.
Adley BP; Gleason KJ; Yang XJ; Stack MS
Gynecol Oncol; 2009 Feb; 112(2):319-24. PubMed ID: 18976802
[TBL] [Abstract][Full Text] [Related]
7. Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.
Liu C
Clin Exp Med; 2016 Aug; 16(3):375-82. PubMed ID: 26123901
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis.
Jia H; Zhang Q; Liu F; Zhou D
Arch Gynecol Obstet; 2017 Mar; 295(3):689-696. PubMed ID: 27995372
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis.
Li LN; Zhou X; Gu Y; Yan J
Asian Pac J Cancer Prev; 2013; 14(7):4107-13. PubMed ID: 23991961
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers.
Jiang L; Siu MK; Wong OG; Tam KF; Lam EW; Ngan HY; Le XF; Wong ES; Chan HY; Cheung AN
Mol Cancer; 2010 Dec; 9():318. PubMed ID: 21176152
[TBL] [Abstract][Full Text] [Related]
11. Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosis.
Trudel D; Desmeules P; Turcotte S; Plante M; Grégoire J; Renaud MC; Orain M; Bairati I; Têtu B
Mod Pathol; 2014 Oct; 27(10):1394-404. PubMed ID: 24603589
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in MMP-14 and MMP-2 genes and ovarian cancer survival.
Vos MC; van Tilborg A; Brands WJ; Boll D; van Hamont D; van der Putten H; Pijlman B; van der Wurff AAM; van Kuppevelt TH; Massuger LFAG
Cancer Biomark; 2019; 25(3):233-241. PubMed ID: 31282404
[TBL] [Abstract][Full Text] [Related]
13. Activated EphA2 Processing by MT1-MMP Is Involved in Malignant Transformation of Ovarian Tumours
Takahashi Y; Hamasaki M; Aoki M; Koga K; Koshikawa N; Miyamoto S; Nabeshima K
Anticancer Res; 2018 Jul; 38(7):4257-4266. PubMed ID: 29970559
[TBL] [Abstract][Full Text] [Related]
14. The expression of tumor-derived and stromal-derived matrix metalloproteinase 2 predicted prognosis of ovarian cancer.
Fu Z; Xu S; Xu Y; Ma J; Li J; Xu P
Int J Gynecol Cancer; 2015 Mar; 25(3):356-62. PubMed ID: 25695542
[TBL] [Abstract][Full Text] [Related]
15. Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.
Brun JL; Cortez A; Lesieur B; Uzan S; Rouzier R; Daraï E
Oncol Rep; 2012 Apr; 27(4):1049-57. PubMed ID: 22200690
[TBL] [Abstract][Full Text] [Related]
16. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.
Cowden Dahl KD; Zeineldin R; Hudson LG
Mol Cancer Res; 2007 May; 5(5):413-21. PubMed ID: 17475671
[TBL] [Abstract][Full Text] [Related]
17. Primary Ovarian Tumors With Lymphogenic and Hematogenic Metastasis Express High MMP-14, Which Colocalizes With Highly Sulfated Chondroitin Sulfate in the Stroma.
Vos MC; Hollemans E; van der Steen SCHA; van Kuppevelt TH; van der Wurff AAM; Massuger LFAG
Int J Gynecol Pathol; 2020 Mar; 39(2):184-192. PubMed ID: 30741846
[TBL] [Abstract][Full Text] [Related]
18. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.
Moss NM; Barbolina MV; Liu Y; Sun L; Munshi HG; Stack MS
Cancer Res; 2009 Sep; 69(17):7121-9. PubMed ID: 19706774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
